Coraline Dubot

Researcher Next ID · RN-017112

Researcher · Medicine

, Luxembourg

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Ovarian cancer diagnosis and treatment

PARP inhibition in cancer therapy

BRCA gene mutations in cancer

Endometrial and Cervical Cancer Treatments

Advanced Breast Cancer Therapies

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
New England Journal of Medicine · 2021 · 10.1056/nejmoa2112435
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology · 2021 · 10.1016/s1470-2045(21)00073-5
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
New England Journal of Medicine · 2019 · 10.1056/nejmoa1911361
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30469-2
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00188-6

No projects listed.